Revvity (NYSE:RVTY) Hits New 1-Year High – What’s Next?

Revvity Inc. (NYSE:RVTYGet Free Report) hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $120.77 and last traded at $120.83, with a volume of 115795 shares trading hands. The stock had previously closed at $113.75.

Analyst Ratings Changes

RVTY has been the topic of a number of analyst reports. Sanford C. Bernstein initiated coverage on Revvity in a research report on Friday, June 26th. They issued a “market perform” rating and a $115.00 price target on the stock. JPMorgan Chase & Co. decreased their price target on shares of Revvity from $96.00 to $90.00 and set a “neutral” rating for the company in a research note on Wednesday, May 6th. TD Cowen reiterated a “buy” rating on shares of Revvity in a report on Wednesday, July 15th. Zacks Research raised shares of Revvity from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 4th. Finally, Robert W. Baird set a $117.00 price target on Revvity in a research report on Wednesday, May 6th. Three equities research analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company. Based on data from MarketBeat, Revvity has an average rating of “Hold” and a consensus target price of $108.36.

Get Our Latest Research Report on Revvity

Revvity Stock Performance

The company has a 50-day simple moving average of $110.94 and a two-hundred day simple moving average of $100.20. The company has a quick ratio of 1.50, a current ratio of 1.80 and a debt-to-equity ratio of 0.36. The firm has a market cap of $13.84 billion, a PE ratio of 59.06, a PEG ratio of 2.18 and a beta of 1.07.

Revvity (NYSE:RVTYGet Free Report) last announced its earnings results on Tuesday, August 4th. The company reported $1.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.21 by $0.20. The firm had revenue of $729.69 million during the quarter, compared to analyst estimates of $702.96 million. Revvity had a return on equity of 8.34% and a net margin of 8.16%.The business’s revenue was down 1.3% compared to the same quarter last year. During the same period last year, the firm posted $1.18 EPS. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. As a group, equities research analysts forecast that Revvity Inc. will post 5.36 earnings per share for the current year.

Revvity Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Friday, October 23rd will be issued a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Friday, October 23rd. Revvity’s dividend payout ratio (DPR) is 13.33%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Ascentis Independent Advisors bought a new stake in shares of Revvity in the 1st quarter worth approximately $29,000. CYBER HORNET ETFs LLC purchased a new position in Revvity in the second quarter valued at approximately $32,000. MUFG Securities EMEA plc bought a new position in Revvity during the second quarter valued at $34,000. Global Retirement Partners LLC bought a new position in Revvity during the second quarter valued at $51,000. Finally, Headlands Technologies LLC purchased a new stake in Revvity in the second quarter worth $49,000. 86.65% of the stock is currently owned by hedge funds and other institutional investors.

About Revvity

(Get Free Report)

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.

Featured Stories

Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.